ENTPD1 and neoplasm: As adenosine-mediated immunosuppression constitutes one of many mechanisms utilized by tumors to escape from neoantigen-induced anti-tumor immune responses, overexpression of CD39, CD73 and A2A receptors in the tumor microenvironment further correlates with poor survival and therapy response.